learn Osteopontin
signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss
Search
forResearch
5 / 1000+ results
research Subcutaneous Injection of Genetically Engineered Exosomes for Androgenic Alopecia Treatment
EX104 shows promise in treating hair loss by promoting hair growth and improving scalp health.
research Subcutaneous Injection of Genetically Engineered Exosomes for Androgenic Alopecia Treatment
EX104 effectively promotes hair growth and regenerates follicles in androgenetic alopecia.
research Exosomes and Their Bioengineering Strategies in Cutaneous Wound Healing and Related Complications: Current Knowledge and Future Perspectives
Engineered exosomes show promise for improving wound healing but face challenges in clinical use.
research Engineered Exosomes Co-Delivering EGF and FGF Ameliorate Androgenetic Alopecia in a Mouse Model
Engineered exosomes with EGF and FGF improved hair growth in mice with hair loss.
research Merkel Cell Carcinoma: Updates in Tumor Biology, Emerging Therapies, and Preclinical Models
New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.
Community Join
5 / 405 resultscommunity Is someone like Elon Musk still on fin and min after hair transplant?
Hair loss treatments, specifically finasteride and minoxidil, being used by wealthy individuals to combat their genetic predisposition to baldness. It also discussed other potential treatments such as RU58841 and dutasteride.
community Fun thought experiment about halting hair loss permamently
A user proposed genetically engineering scalp stem cells to stop androgen receptors from causing hair loss. Others discussed the feasibility, existing research, and potential issues with this approach, including targeting the correct cells and unintended effects.
community Will PP405 be prohibitively expensive or will it be roughly the same as fin or min?
PP405 is expected to be more expensive than finasteride and minoxidil initially due to patent protection, but not as costly as life-saving medications like Ozempic. The price may decrease after the patent expires, but initially, it might be around $100 per month, making it potentially unaffordable for many.
community Topical T3 study - 1000% Growth. Anyone tried it?
The conversation discusses using T3 (triiodothyronine) as a topical treatment for hair growth, with some users noting it showed promising results in studies but lacked follow-up. Users express interest in trying T3 due to its potential effectiveness compared to Minoxidil.
community Binding affinity of pyrilutamide!
Pyrilutamide, a nonsteroidal antiandrogen drug under development for the potential treatment of androgenic alopecia. The conversation discusses its binding affinity to the androgen receptor and the timeline for possible availability after trials are completed in the United States and China.